rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

AMN Healthcare Services Inc

AMN · NYSE

IndustrialsProfessional ServicesLeading

AMN stood above a rising 150-day average in 26 of the last 52 weekly readings, including each of the last 25 weeks. It is 43.0% above that average now. Professional Services: 33% of its 72 stocks in an uptrend (−1 points in four weeks); Industrials: 28% (−3 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
25 in a row
Industry in uptrend
33% -1 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$229K
Officials’ trades on record
18
Institutions holding
266 (+41)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 26 of 52 weeks.

22 Apr – 21 Oct
23%33%44%Apr 26Jun 26Jul 26Sep 26Oct 26

Professional Services: A minority of its stocks are in an uptrend and the share has held steady. Industrials: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$220K$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

18 disclosed lines: House 18, Senate 0, executive 0; 2 people.

WhoDidAmountTraded
Greg Gianforte House: U.S. House ClerkMT00bought$15k–$50k9 Nov 2020filed 2 Dec 2020
Greg Gianforte House: U.S. House ClerkMT00bought$15k–$50k9 Nov 2020filed 2 Dec 2020
Greg Gianforte House: U.S. House ClerkMT00boughtjoint$1k–$15k2 Sep 2020filed 15 Sep 2020
Greg Gianforte House: U.S. House ClerkMT00bought$1k–$15k2 Sep 2020filed 15 Sep 2020
Greg Gianforte House: U.S. House ClerkMT00bought$1k–$15k2 Sep 2020filed 15 Sep 2020
Greg Gianforte House: U.S. House ClerkMT00bought$1k–$15k2 Sep 2020filed 15 Sep 2020
Greg Gianforte House: U.S. House ClerkMT00bought$1k–$15k2 Sep 2020filed 15 Sep 2020
Greg Gianforte House: U.S. House ClerkMT00bought$1k–$15k2 Sep 2020filed 15 Sep 2020
Greg Gianforte House: U.S. House ClerkMT00bought$1k–$15k2 Sep 2020filed 15 Sep 2020
Greg Gianforte House: U.S. House ClerkMT00bought$1k–$15k2 Sep 2020filed 15 Sep 2020
Greg Gianforte House: U.S. House ClerkMT00bought$1k–$15k2 Sep 2020filed 15 Sep 2020
Greg Gianforte House: U.S. House ClerkMT00bought$15k–$50k31 Aug 2020filed 15 Sep 2020

Insiders

Buy orders, 12 months0
Sale orders, 12 months1
Buyers · sellers0 · 1
WhoDidSharesTraded
Mark G. FolettaDirectorsold1,681at $31.0715 Jun 2026filed 17 Jun 2026
Mark G. FolettaDirectorsold2,000at $31.0715 Jun 2026filed 17 Jun 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders266+41 on the quarter
New · exited75 · 35
Reported value$1.4B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20266,643,401$215.0M+619,906+10.3%
MORGAN STANLEYadded · filed 13 Aug 20262,282,597$73.9M+941,922+70.3%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20261,719,045$55.6M+41,619+2.5%
STATE STREET CORPadded · filed 7 Aug 20261,694,316$54.8M+79,912+4.9%
Boston Partnersreduced · filed 4 Aug 20261,674,561$54.2M-463,827−21.7%
Allianz Asset Management GmbHadded · filed 14 Aug 20261,402,948$44.0M+141,944+11.3%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPreduced · filed 13 Aug 20261,391,859$45.1M-9,866−0.7%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 20261,288,073$41.7M+163,404+14.5%
DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 20261,283,381$41.5M+542,172+73.1%
TWO SIGMA INVESTMENTS, LPreduced · filed 14 Aug 20261,158,258$37.5M-429,423−27.0%
31 Mar 2023 – 30 Jun 2026
223294365Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Mark Christopher Hagan Company insiderChief Information and Digital · last 15 Oct 20260 · 3
Whitney M. Laughlin Company insiderChief Legal Officer · last 15 Oct 20261 · 0
Mark G. Foletta Company insiderDirector · last 15 Jun 20261 · 7
Celia P. Huber Company insiderDirector · last 1 May 20260 · 0
Daphne E. Jones Company insiderDirector · last 1 May 20260 · 1
Eric P. Palmer Company insiderDirector · last 1 May 20260 · 0
James H. Hinton Company insiderDirector · last 1 May 20260 · 0
Jorge A. Caballero Company insiderDirector · last 1 May 20261 · 0
R. Jeffrey Harris Company insiderDirector · last 1 May 20262 · 4
Sylvia Trent-Adams Company insiderDirector · last 1 May 20261 · 0
Teri G. Fontenot Company insiderDirector · last 1 May 20261 · 0
Brian M. Scott Company insiderCFO/COO · last 15 Jan 20261 · 31

Same industry

NEO NeoGenomicsLeading+29%
NSP InsperityLeading+21%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202528.3%
Operating profit marginFY 2025 · to 31 Dec 2025-2.0%
Free cash flow marginFY 2025 · to 31 Dec 20258.6%
Return on capital employedFY 2025 · to 31 Dec 2025-3.7%
Debt to equityFY 2025 · to 31 Dec 20251.19×
Share count trendFY 2025 · to 17 Feb 20260.5%
Cash and equivalentsFY 2025 · to 31 Dec 2025$34.0M
Free cash flowFY 2025 · to 31 Dec 2025$233.8M

Analyst forecasts

No analyst forecasts yet.